openPR Logo
Press release

Tumor Embolization Devices Market Growth Accelerates: Strategic Forecast Predicts $2286.1 Billion by 2029

08-21-2025 02:04 PM CET | Health & Medicine

Press release from: The Business Research Company

Tumor Embolization Devices

Tumor Embolization Devices

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Tumor Embolization Devices Industry Market Size Be by 2025?
The market size for tumor embolization devices has experienced robust growth in the past few years. It is projected to increase from $1493.6 billion in 2024 to $1600.57 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The historical growth can be credited to the advent of minimally invasive procedures, technological developments, the prevalence of cancer and an aging demographic.

What's the Long-Term Growth Forecast for the Tumor Embolization Devices Market Size Through 2029?
In the upcoming years, the market size of tumor embolization devices is anticipated to experience robust growth, expected to reach $2286.1 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The growth projected during the forecast period is due largely to factors such as personalized medicine, combination therapies, image-guided embolization, telemedicine, and remote consultations. Significant trends anticipated for the forecast period encompass innovations in embolic agents, transarterial chemoembolization (tace), palliative care embolization, and image-guided procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

What Are the Key Growth Drivers Fueling the Tumor Embolization Devices Market Expansion?
The increase in global cancer incidences is predicted to drive the expansion of the tumor embolization devices market in the coming years. For example, Macmillan Cancer Support, the UK's biggest healthcare charity, suggested in October 2022 that by 2025, the number of people with cancer will reach 3.5 million, by 2030 it will be 4 million, and by 2040, 5.3 million. Consequently, the growing rate of cancer worldwide is expected to enhance the demand for the tumor embolization market in the future years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

What Are the Key Trends Driving Tumor Embolization Devices Market Growth?
Key operators in the tumor embolization devices market are focusing on product innovation such as angiography systems to improve the precision and efficiency of treatments aimed specifically at tumors. These angiography systems are specialized imaging tools that are used to examine blood vessels and analyze blood flow within the human body. For example, in June 2022, Siemens Healthineers, a healthcare firm based out of Germany, unveiled the Artis Icono Ceiling. This is a ceiling-mounted angiography system designed to increase accuracy in tumor embolization and other types of interventional procedures. The Artis Icono Ceiling has a quick 3D data collection feature that can acquire images at the patient's head in just 2.5 seconds and from sideway angles in 4 seconds, reducing motion distortion and lessening the requirement for contrast media. Designed with versatility in mind, the Artis Icono Ceiling can be used in a range of specialties, including interventional radiology and cardiology.

How Is the Tumor Embolization Devices Market Segmented?
The tumor embolization devices market covered in this report is segmented -

1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol - PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3352&type=smp

Which Companies Are Leading the Charge in Tumor Embolization Devices Market Innovation?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

Which Regions Are Leading the Global Tumor Embolization Devices Market in Revenue?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Embolization Devices Market Growth Accelerates: Strategic Forecast Predicts $2286.1 Billion by 2029 here

News-ID: 4154284 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Tumor

Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Expected Carcinoid Tumor Market Size During the Forecast Period? In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.
10-01-2024 | Health & Medicine
Getnews
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg Brain Tumor Foundation October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949 This latest report researches the industry structure,
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market. Request Access Global Wilms Tumor Market
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the